Hikal
Hikal Limited, a prominent player in the pharmaceutical and agrochemical sectors, is headquartered in India. Established in 1988, the company has made significant strides in providing high-quality active pharmaceutical ingredients (APIs) and intermediates, alongside a diverse range of agrochemical products. With a strong operational presence across India and international markets, Hikal has positioned itself as a trusted partner for global pharmaceutical and agricultural companies. Hikal's core offerings include custom synthesis, contract manufacturing, and a robust portfolio of APIs that cater to various therapeutic areas. The company is recognised for its commitment to quality and innovation, which has earned it several industry accolades. As a leader in its field, Hikal continues to drive advancements in sustainable practices and technology, solidifying its reputation as a key contributor to the global healthcare and agriculture landscape.
DitchCarbon Score
How does Hikal's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hikal's score of 17 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hikal's reported carbon emissions
In 2023, Hikal reported total carbon emissions of approximately 94,700,000 kg CO2e, comprising about 26,793,240 kg CO2e from Scope 1 and about 67,737,300 kg CO2e from Scope 2 emissions. This represents a reduction from 2022, where Scope 1 emissions were about 57,457,000 kg CO2e. For 2024, Hikal's emissions are projected to be approximately 88,000,000 kg CO2e, with Scope 1 emissions at about 21,410,710 kg CO2e and Scope 2 emissions at about 67,287,010 kg CO2e. This indicates a continued commitment to reducing their carbon footprint. Hikal has committed to near-term reduction targets, although specific numerical targets have not been disclosed. The company is not currently committed to a net-zero target. Their emissions intensity metrics indicate a focus on improving efficiency, with Scope 1 and 2 emission intensity per rupee of turnover reported at 0.00467 in 2023 and 0.00497 in 2024. As a player in the Pharmaceuticals, Biotechnology, and Life Sciences sector, Hikal is actively working towards reducing its environmental impact while navigating the challenges of climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 57,457,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hikal is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
